Sotalol hydrochloride is the active ingredient in Betapace
AF, a treatment for irregular heart rhythms made by Schering AG unit Berlex Inc.
Other launches during 2004 include seven strengths of Amphetamines Mixed Salts tablets (reference: Adderall tablets, Shire Pharmaceuticals Group), Sotalol AF tablets (reference: Betapace
AF tablets, Berlex Laboratories), Phentermine 37.
Berlex Laboratories, which markets the drug as Betapace
, filed a supplemental application for approval of this indication.
Anti-arrhythmia medications such asTambocor, Rhythmol, Procanbid, Betapace
, Norpace, or Quinidex